Navigation Links
RuiYi and Genor BioPharma Collaborate on Development in China of RYI-008, a Novel Therapeutic for Autoimmune Diseases and Cancer
Date:5/16/2013

LA JOLLA, Calif. and SHANGHAI, May 16, 2013 /PRNewswire/ -- RuiYi Inc. announced today that it has entered into an exclusive license and collaborative development agreement with Genor BioPharma for the development of RYI-008 in China. RYI-008 is a novel anti-IL-6 monoclonal antibody with a unique pharmacologic profile that has the potential to define a new paradigm in the treatment of autoimmune diseases and cancer.

"RYI-008, with its unprecedented femtamolar potency and amazing long half-life has a therapeutic profile of once monthly, low milligram, subcutaneous dosing," said Paul Grayson , president and CEO of RuiYi. "RYI-008 is a tremendous candidate for this novel development strategy, with approximately 4.1 million biologic treatment naive rheumatoid arthritis patients in China in need of a cost effective therapeutic option.  The team at Genor has deep global development experience and strong commercial, regulatory, and government relationships in China, making them the ideal development partner. We look forward to working with them to deliver novel, breakthrough therapeutics for the Chinese healthcare system."

Joe Zhou , CEO of Genor BioPharma, commented, "The clinical data on IL-6 modulation continues to be extremely favorable in multiple diseases.  The selection by RuiYi and Genor of RYI-008 for development shows a unique understanding of a changing healthcare environment in China where the cost-effective delivery of novel efficacious medicines is of significant importance."

About RYI-008

RYI-008, also known as ARGX-109, is a novel, extremely potent monoclonal antibody that is highly selective to IL-6, a cytokine widely implicated in inflammation and cancer. The antibody was discovered by arGEN-X, Gh
'/>"/>

SOURCE RuiYi Inc.; Genor BioPharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CMC Biologics und RuiYi Enter treffen Vereinbarung zur Entwicklung eines neuartigen monoklonalen Anti-IL-6-Antikörpers
2. CMC Biologics et RuiYi passent un accord pour le développement dun nouvel anticorps monoclonal Anti-IL-6
3. CMC Biologics and RuiYi Enter into an Agreement for Development of a Novel Anti-IL-6 Monoclonal Antibody
4. Array BioPharma Announces Clinical Data Presentations At The 2013 ASCO Annual Meeting
5. Callidus Biopharma Announces $4.6 million in Series A Financing to Pursue Orphan Disease Therapies
6. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2013 Financial Results
7. Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2013
8. PDL BioPharma to Announce First Quarter 2013 Financial Results on May 9, 2013
9. Rutgers Business School and the Blanche and Irwin Lerner Center will explore trends and issues facing the biopharmaceutical industry at a healthcare symposium, Tuesday, April 30
10. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
11. New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... GRAFTON, Wis. , May 4, 2015 /PRNewswire/ ... of high-quality consumables used in dental restorative procedures, ... is a producer of an innovative sectional matrix ... "We are excited about the opportunity to ... accessories," said John Frymark , VP and ...
(Date:5/4/2015)... , May 4, 2015  Fox Three Partners, ... on the lower middle market, announced today the ... in 1969 and based in Newport ... range of radiation products for medical professionals as ... with Peninsula Capital Partners ("Peninsula"), an investment company ...
(Date:5/4/2015)...   The New York Times sought out ... plastic surgeon, Dr. Rod Rohrich . Kybella, recently ... to reduce fat deposits under the chin. ... active ingredient in Kybella, deoxycholic acid, dissolves the fat ... to reshape this area without surgery. "So many consumers ...
Breaking Medicine Technology:Microbrush International Announces Acquisition of DentiSmart 2Fox Three Partners, LLC Acquires Burlington Medical Supplies, Inc. 2Dr. Rod Rohrich Provides Medical Expertise on Kybella 2Dr. Rod Rohrich Provides Medical Expertise on Kybella 3
... 2010 Valeant Pharmaceuticals International, Inc. (NYSE: ... Board of Directors (the "Board") has declared a one-time ... Dividend") that shareholders of record as of the close ... will be entitled to receive on December 22, 2010. ...
... Ind., Nov. 3, 2010 Symmetry Medical Inc. (NYSE: ... the global orthopaedic device industry and other medical markets, announced ... secured revolving credit facility, effective November 3, 2010.  The credit ... borrowing capacity up to $300 million. The credit facility has ...
Cached Medicine Technology:Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan 2Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan 3Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan 4Symmetry Medical Closes $200 Million Credit Facility 2Symmetry Medical Closes $200 Million Credit Facility 3
(Date:5/5/2015)... May 05, 2015 Buckeye Health Plan ... new CEO and plan president of Buckeye Health Plan. ... the position immediately. , Hill has more than 28 ... the Pacific Northwest, from managed care to large health ... and CEO of HealthPlus of Michigan, a health plan ...
(Date:5/5/2015)... San Francisco, California (PRWEB) May 05, 2015 ... company based in San Francisco, leads an international initiative ... in order to extend the human lifespan. Scientists ... clocks inherent to women, from the initiation of her ... reveal a possible mechanism for aging and, ultimately, extend ...
(Date:5/5/2015)... May 05, 2015 HealthSlide, ... innovative interoperability solutions for hospitals nationwide, has announced ... calculator. Hospital CIOs and CTOs can access the ... calculator shows both initial and ongoing savings of ... , “Our nation’s hospitals pay an average of ...
(Date:5/5/2015)... 05, 2015 After record-breaking sales of ... 2014, Walgreens introduces the Cookies & Cream flavor at ... Extend Nutrition has continually raised the bar for nutritional ... combined with an unprecedented nutritional profile, backed by international ... Extend Nutrition will launch additional new products and expand ...
(Date:5/5/2015)... OR (PRWEB) May 05, 2015 Every year, ... eye seasons. Turns out, the worst dry eye season is ... count spikes in most of the United States. The only ... Fresh water advocate Sharon Kleyne, host of the Sharon Kleyne ... eye on her radio show of May 11, 2015. Kleyne ...
Breaking Medicine News(10 mins):Health News:Buckeye Health Plan Announces New Chief Executive Officer 2Health News:Buckeye Health Plan Announces New Chief Executive Officer 3Health News:Igantia Announces Digital Initiative to Decode Longevity 2Health News:HealthSlide Launches ROI Cost Calculator 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 2Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 3
... International, http://www.heifer.org, a world hunger organization, provides ... the hard-to-shop-for,person who says, "Please, no more stuff!" ... one thing well: Helping impoverished families who,are among ... $2 a day gain better,livelihoods by providing livestock ...
... Designs for Health, Inc., a leading provider of science-based nutritional ... practice management software packages-- eHealthPro™ and eNatro™--from Enova Inc, a ... ... Windsor, CT (PRWEB) October 20, 2008 -- Designs for Health, ...
... edge whitening system. Manhattan dentist claims Pearlinbrite is more effective ... effective and precise than other options. , ... New ... spent the last 25 years developing Pearlinbrite, a unique in-office laser ...
... of treatment received have an impact on a non-Hodgkin lymphoma ... a new study published in the December 1, 2008 issue ... Cancer Society. The study reveals that poorer socioeconomic status increases ... risk. , NHL is a common type of cancer in ...
... feature story on Mary Hall will appear on http://fortlauderdalecitylimits.com . ... ... -- Mary Hall, CEO of iHealthspot, Inc. a leading provider of ... Fort Lauderdale City Limits "Profiles of Excellence" in the Advertising & ...
... Oct. 17 In the U.S., approximately one,in eight ... about 1.2,million couples visit a fertility specialist for help ... must-have, go-to resource for any woman who,wants to keep ... --,now, soon, or later. Conceive,s readers are thinking about ...
Cached Medicine News:Health News:Heifer International: The Greener Good for Holiday Giving 2Health News:Designs for Health Acquires eHealthPro™ and eNatro™ Practice Management Software 2Health News:Designs for Health Acquires eHealthPro™ and eNatro™ Practice Management Software 3Health News:Designs for Health Acquires eHealthPro™ and eNatro™ Practice Management Software 4Health News:Dr. Jan Linhart Now Offerring Unique Laser Teeth Whitening System 2Health News:Socioeconomic and treatment factors affect non-Hodgkin lymphoma patients' survival 2Health News:Mary Hall, CEO of iHealthSpot, Inc., is Awarded Membership Into Fort Lauderdale City Limits "Profiles of Excellence" 2Health News:Conceive Magazine Introduces a Special Issue: 'The Birds, The Bees, and Modern Medicine' 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: